FDA Updates Cosmetics Direct Portal Ahead of Biennial Facility Renewals

The U.S. Food and Drug Administration (FDA) recently announced updates to its Cosmetics Direct portal and supporting educational materials to help cosmetic manufacturers and processors prepare for upcoming biennial registration renewals under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The updates are designed to improve usability, increase compliance visibility, and simplify the renewal process for cosmetic facilities importing or manufacturing products for the U.S. market.

The announcement comes as the Cosmetics Direct portal approaches its two-year anniversary. Since launching in December 2023, more than 14,000 cosmetic product facilities have registered with the FDA through the system.

Under MoCRA, cosmetic manufacturers and processors are required to register their facilities with the FDA and renew those registrations every two years. The FDA’s recent portal updates aim to make that process easier and reduce the likelihood of missed deadlines or incomplete submissions.

What’s New in the Cosmetics Direct Portal?

The FDA introduced several new features and improvements within Cosmetics Direct, including:

  • Facility registration status visibility
  • Displayed renewal due dates
  • Automated renewal reminder emails
  • Updated user guides and tutorials
  • Clarified renewal instructions for facilities

These updates are especially important as cosmetic companies begin preparing for their first required biennial renewals under MoCRA. Renewal dates are based on the original facility registration date. For example, if a facility originally registered on February 20, 2024, its renewal would generally be due on February 20, 2026.

The FDA also clarified that facilities now have two electronic renewal pathways available through Cosmetics Direct:

  1. Biennial Renewal — used when facility information has changed
  2. Abbreviated Renewal — used when no registration changes are needed

Paper submission options remain available, although the FDA strongly encourages electronic filing through Cosmetics Direct for faster processing and easier tracking.

Why This Matters for Cosmetic Brands and Importers

MoCRA represents the largest expansion of FDA cosmetic oversight since 1938 and significantly changes how cosmetic businesses operate in the United States. The law now requires mandatory facility registration, product listing, adverse event reporting, safety substantiation, and increased documentation obligations for cosmetic manufacturers and importers.

For importers and private-label cosmetic brands, these portal improvements are more than administrative updates. Missed renewals or inaccurate facility registrations could increase the risk of:

  • Shipment delays
  • Import detentions
  • FDA enforcement actions
  • Customs clearance issues
  • Marketplace compliance problems

Companies relying on overseas manufacturers should also ensure suppliers understand FDA renewal obligations and maintain accurate registration information.

Preparing for Biennial Registration Renewal

Cosmetic businesses should begin preparing for renewal well before their deadline arrives. Recommended preparation steps include:

  • Reviewing current facility registration information
  • Confirming facility ownership and contact information
  • Verifying FDA Establishment Identifier (FEI) numbers
  • Updating brand and manufacturing details
  • Reviewing product claims for compliance concerns
  • Monitoring Cosmetics Direct renewal notifications

The FDA also updated tutorials and instructional materials to help facilities better understand the submission process. These resources are especially helpful for smaller brands and first-time importers still adapting to MoCRA requirements.

A Continued Shift Toward Cosmetic Supply Chain Accountability

The FDA’s continued investment in Cosmetics Direct signals a broader shift toward long-term regulatory oversight and cosmetic supply chain accountability. As MoCRA implementation continues, businesses should expect increased attention on facility transparency, registration accuracy, ingredient documentation, and importer responsibility.

Companies that proactively manage their FDA registrations and maintain organized compliance records will be better positioned to avoid costly disruptions while building stronger relationships with retailers, consumers, and regulatory agencies.

返回博客